Your browser doesn't support javascript.
loading
Injections and infections: understanding syringe service program utilization in a rural state.
Thakarar, Kinna; Sankar, Nitysari; Murray, Kimberly; Lucas, Frances L; Burris, Debra; Smith, Robert P.
Afiliación
  • Thakarar K; Center for Outcomes Research and Evaluation/Maine Medical Center Research Institute, 509 Forest Ave, Portland, ME, USA. kthakarar@mmc.org.
  • Sankar N; Department of Medicine, Maine Medical Center, 22 Bramhall Street, Portland, ME, USA. kthakarar@mmc.org.
  • Murray K; Tufts University School of Medicine, 145 Harrison Ave, Boston, MA, USA. kthakarar@mmc.org.
  • Lucas FL; Maine Medical Partners Adult Infectious Diseases, 41 Donald Bean Drive, Suite B, South Portland, ME, 04106, USA. kthakarar@mmc.org.
  • Burris D; University of New England College of Osteopathic Medicine, Biddeford, ME, USA.
  • Smith RP; Center for Outcomes Research and Evaluation/Maine Medical Center Research Institute, 509 Forest Ave, Portland, ME, USA.
Harm Reduct J ; 18(1): 74, 2021 07 17.
Article en En | MEDLINE | ID: mdl-34273986
ABSTRACT

BACKGROUND:

Increasing rates of injection drug use (IDU) associated-infections suggest significant syringe service program (SSP) underutilization. Our study objective was to assess practices of safe injection techniques and to determine predictors of SSP utilization in a rural state. PATIENTS AND

METHODS:

This was a fifteen-month cross-sectional study of participants hospitalized with IDU-associated infections in Maine. Data were collected through Audio Computer-Assisted Self-Interview survey and medical record review. Descriptive analyses were performed to characterize demographics, health characteristics, and injection practices. The primary outcome was SSP utilization, and the main independent variable was self-reported distance to SSP. Logistic regression analyses were performed to identify factors associated SSP utilization, controlling for gender, homelessness, history of overdose, having a primary care physician and distance to SSP.

RESULTS:

Of the 101 study participants, 65 participants (64%) reported past 3 month SSP utilization, though only 33% used SSPs frequently. Many participants (57%) lived more than 10 miles from an SSP. Participants who lived less than 10 miles of an SSP were more likely to use an SSP (adjusted odds ratio 5.4; 95% CI 1.9-15.7).

CONCLUSIONS:

Our study highlights unsafe injection practices and lack of frequent SSP utilization among people admitted with IDU-associated infections in a rural state. Especially given increasing stimulant use, these results also highlight the need for SSP access. Particularly in rural areas where patients may live more than 10 miles from an SSP, expansion of harm reduction services, including mobile units, should be a priority.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Jeringas / Abuso de Sustancias por Vía Intravenosa Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Harm Reduct J Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Jeringas / Abuso de Sustancias por Vía Intravenosa Tipo de estudio: Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Harm Reduct J Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos